What is the generic name?

BRINZOLAMIDE/BRIMONIDINE TARTRATE

What is the Trade Name for BRINZOLAMIDE/BRIMONIDINE TARTRATE?

SIMBRINZA

What are the Indications for BRINZOLAMIDE/BRIMONIDINE TARTRATE?

• 1 INDICATIONS AND USAGE SIMBRINZA (brinzolamide and brimonidine tartrate ophthalmic suspension) 1% and 0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. SIMBRINZA is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

References: https://open.fda.gov/